Tracers / [177Lu]Lu-pepa-pic2-C-Hex-KuE
[177Lu]Lu-pepa-pic2-C-Hex-KuE
Also written as [Lu-177]Lu-pepa-pic2-C-Hex-KuE
- Radionuclide
- Lu-177 t½ 9584.6 min
- Modality
- Therapy
- Production route
- —
- Stage
- Reported once
- Syntheses indexed
- 2
What it is
- Compound class
- PSMA-targeting urea-based (C-Hex-KuE) small molecule with pepa-pic2 trifunctional chelator
- Target / mechanism
- Prostate-specific membrane antigen (PSMA) PMID 41324598
- Clinical application
- —
- Theranostic pair
- —
Regulatory status
- FDA
- —
- EMA (centralised)
- —
- Other approvals
- —
- Brand names
- —
Clinical use
- Typical injected activity
- —
- Uptake time
- —
Reported in the literature. Not a dosing recommendation.
Published syntheses
| Module | Cassette | Purification | Yield % | RCP % | Precursor / supplier | Source |
|---|---|---|---|---|---|---|
| Manual synthesis | — | — | — | — | pepa-pic2-C-Hex-KuE | 41324598 2025 J Am Chem Soc The formation of [177Lu]Lu-pepa-pic2-C-Hex-KuE and [161Tb]Tb-pepa-pic2-C-Hex-KuE was achieved under identical reaction conditions as previously employed for the 86Y analogue (80 °C, pH 5.5) |
| — | — | — | — | exceeding 99% | — | 42097084 2026 Appl Radiat Isot |
Need this precursor?We can point you to suppliers for [177Lu]Lu-pepa-pic2-C-Hex-KuE, or handle the enquiry for you.
Get in touchNotes
Added at stage 22: promoted from 'Reported once' (single-article, no diagnostic pair at discovery) because a full-text synthesis with extracted data exists in parsed-therapy.xlsx -- PMID(s): 41324598. Target/mechanism, clinical application, indications, approval and precursor fields still need per-agent research and are intentionally left empty. Compound class inferred from precursor name (not stated outright) -- PMID 41324598: 'pepa-pic2-C-Hex-KuE'.